Escherichia coli ST131 Drives Carbapenem Use for E. Coli Bloodstream Infections

Mackow NA, Shao W, Ge L, Komarow L, Jiang J, Boutzoukas A, Chen L, Garcia-Diaz J, Herc ES, Doi Y, Arias CA, Albin O, Saade E, Miller LG, Jacob JT, Satlin MJ, Krsak M, Huskins WC, Dhar S, Shelburne SA, Hill C, Alby K, Sadler JM, Hill BM, Greenwood-Quaintance KE, Schmidt-Malan SM, Patel R, Fowler VG Jr, Tamma PD, Kreiswirth BN, van Duin D; Antibacterial Resistance Leadership Group. Escherichia coli ST131 Drives Carbapenem Use for E. Coli Bloodstream Infections. Clin Infect Dis. 2026 Mar 6:ciag160. doi: 10.1093/cid/ciag160. Epub ahead of print. PMID: 41795867.


Related Posts